Flow Cytometry Core Abstract: The flow cytometry core laboratory (FCCL) was initiated at the end of the phase I of the COBRE program. The two instruments that are used most often were purchased through a private donation and COBRE provided the funds to employ an operator, maintain the equipment, and purchase the necessary consumables. Initially, the FCCL served COBRE-funded investigators, but quickly grew to be an essential component of the infrastructure of the KUMC research community. The core has served 72 investigators in the Kansas City area during the past year. As the user base of the FCCL has grown, so has the staffing and instrumentation. We added a second flow cytometer, Luminex, laser scanning microscope, Celigo, and RoboSep. We also added a biosafety room in which we can FACS-purify human and non-human primate cells. In addition, we added two personnel: a manager and a flow cytometry technician. We established an internal flow advisory committee (IFAC) and an external flow advisory committee (EFAC) to monitor the progress of the FCCL as we progress toward a sustainable business model. Procedures for investigators to use the FCCL are centered around mentoring and training. We mentor investigators as to the best technology available to address their scientific questions. We also counsel investigators as to the best combination of reagents available to successfully complete the experiments. Once users are ready to perform the experiments, we advise them regarding experimental technique. Then, we train each user individually in the operation of the relevant equipment. Once data are obtained, we train the user to analyze and interpret the data. At the completion of the investigator's experience with the FCCL, they understand why the technology used is the best for their biological question, how to prepare the samples, acquire the data, analyze the data, and present the data.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kansas
Kansas City
United States
Zip Code
Ozias, Marlies K; Li, Shengqi; Hull, Holly R et al. (2015) Abdominal visceral adiposity influences CD4+ T cell cytokine production in pregnancy. Cytokine 71:405-8
Borrego-Diaz, Emma; Powers, Benjamin C; Azizov, Vugar et al. (2014) A potential regulatory loop between Lin28B:miR?212 in androgen-independent prostate cancer. Int J Oncol 45:2421-9
Sands, Scott A; Tsau, Sheila; Yankee, Thomas M et al. (2014) The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice. BMC Res Notes 7:605
Williams, C David; Bajt, Mary Lynn; Sharpe, Matthew R et al. (2014) Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. Toxicol Appl Pharmacol 275:122-33
Aljitawi, Omar S; Xiao, Yinghua; Eskew, Jeff D et al. (2014) Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34ýýý cells in a murine model of umbilical cord blood transplantation. Blood Cells Mol Dis 52:59-67
Xiong, Juan; Parker, Brooks L; Yankee, Thomas M (2014) The combined loss of Gads and CD127 reveals a novel function of Gads prior to TCR? expression. Immunol Res 60:77-84
Zückert, Wolfram R (2014) Secretion of bacterial lipoproteins: through the cytoplasmic membrane, the periplasm and beyond. Biochim Biophys Acta 1843:1509-16
Girinathan, Brintha Prasummanna; Braun, Sterling E; Govind, Revathi (2014) Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2. Microbiology 160:47-55
Sirigi Reddy, Apoorva Reddy; Girinathan, Brintha Parasumanna; Zapotocny, Ryan et al. (2013) Identification and characterization of Clostridium sordellii toxin gene regulator. J Bacteriol 195:4246-54
Luo, Yong; Deng, Xuefeng; Cheng, Fang et al. (2013) SMC1-mediated intra-S-phase arrest facilitates bocavirus DNA replication. J Virol 87:4017-32

Showing the most recent 10 out of 12 publications